Advanced Nuclear Medicine and Molecular Imaging in the Diagnosis of Cardiomyopathy

Ming Yang, Reza Arsanjani, Michael C. Roarke

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


OBJECTIVE. The purpose of this article is to summarize the protocol, interpretation, and diagnostic performance of nuclear medicine and molecular imaging in imaging two distinctive, underdiagnosed cardiomyopathies: cardiac amyloidosis and cardiac sarcoidosis. CONCLUSION. Emerging new radiotracers and advanced molecular imaging modalities enable us to noninvasively characterize certain types of cardiomyopathies, including cardiac amyloidosis and cardiac sarcoidosis, with great confidence. We expect to improve recognition and promote the application of such advanced techniques in the imaging and management of these potentially lethal cardiomyopathies.

Original languageEnglish (US)
Pages (from-to)1208-1217
Number of pages10
JournalAmerican Journal of Roentgenology
Issue number5
StatePublished - Nov 2020


  • Cardiac amyloidosis
  • Cardiac sarcoidosis
  • Cardiomyopathy
  • PET

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Advanced Nuclear Medicine and Molecular Imaging in the Diagnosis of Cardiomyopathy'. Together they form a unique fingerprint.

Cite this